Sandoz Group (OTCMKTS:SDZNY) Trading Up 0.8% – Still a Buy?

Sandoz Group AG (OTCMKTS:SDZNY) rose 0.8% on Monday . The stock traded as high as $45.85 and last traded at $45.69. Approximately 25,020 shares traded hands during mid-day trading, a decline of 74% from the average daily volume of 97,949 shares. The stock had previously closed at $45.32.

Wall Street Analysts Forecast Growth

Separately, Royal Bank of Canada cut Sandoz Group from a “moderate buy” rating to a “hold” rating in a research report on Monday, September 16th.

Sandoz Group Stock Performance

The stock has a 50-day simple moving average of $43.54 and a 200 day simple moving average of $40.42.

Sandoz Group Company Profile

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.